Come to that degree amine capsule review! Zhengda sunny 12th over-reviewed varieties were born

　　Pharmaceutical network November 1st, October 30th, Zhengda Tianqing official micro-release news that the Nadu amine capsule (commodity name: AnXian) recently obtained the approval of the State Drug Administration, through the quality and efficacy of generic drugs consistent evaluation China Biopharmaceutical's semi-annual report shows that in the first half of 2019, sales of Nado amine were nearly 100 million yuan, reaching 97.15 million yuan to be the first line of drug use of multiple myeloma, which as a new generation of immunomodulator, with immunomodulation, anti-angiogenesis and anti-tumor characteristics, clinically widely used in multiple myeloma, lymphoma, myeloid hyperplasia syndrome, acute myeloid leukemia and other treatment, is currently the international and domestic treatment of multiple myeloma and myeloma hyperplasia syndrome commonly used drugs in multiple myeloma cells, the synergy between amine and dexamethasone inhibits cell proliferation and leads to apoptosis As a heavy drug for the treatment of multiple myeloma, Rhondosis is the preferred drug for the 2018 edition of the National Comprehensive Cancer Network (NCCN) Multiple Myeloma Guidelines, and is also the first-line treatment, second-line treatment, and relapse-difficult drugs of China's 2017 guidelines for multiple myeloma treatment In 2019, The amine will be included in the National Health Insurance Zhengda Tianqing announced that Anxian was approved for the market in January 2019, approved for indications and original research products in line Zhengda Tianqing to the domestic market of the original research drug as a reference agent, carried out a comprehensive quality comparison study, and strictly abide by the cFDA's latest requirements to carry out bioequivalence research comparative research results show that Zhengda Tianqing Anxian and the original research reference preparation test results are consistent, in vitro dissolved behavior is consistent, impurity spectrum and miscellaneous mass, impurity number are basically the same; This shows that zhengda days sunny Nadoamine capsule (Anxian) and the original research reference preparation has the consistency of quality and efficacy Zhengda Tianqing, through the consistent evaluation of the quality and efficacy of generic drugs, can achieve the clinical replacement of the original drug, provide patients with high-quality low-cost drug use options, enhance the public's sense of , for the country to deepen medical reform and the people's basic drug system construction to contribute to the construction of obvious social benefits rice net data show that the new base of the Inadoamine capsule was approved to enter China in 2013, for the domestic patients with multiple myeloma to provide new drug options In July 2017, 36 negotiated drugs, such as Naldoa, were included in the 2017 edition of the National Health Insurance Catalog (Class B), and in November of the same year, the first domestically produced Lynado amine capsule was approved for production by Beijing Shuangamine Pharmaceuticals, registered as a category 3.1 In 2018, sales of nado's capsules soared to 398 million yuan at the end of China's public medical institutions, with the new base accounting for 96.96 percent and Beijing's Shuangyi Pharmaceuticals accounting for 3.04 percent In 2019, with Zhengda Tianqing Pharmaceutical's 6 types of imitation, Qilu Pharmaceutical's 4 types of imitation series has been approved, the sales of products are expected to reach a new high in addition to Zhengda Tianqing's Narado capsule evaluation, the current Qilu Pharmaceuticals has been approved according to the new classification, in addition to the Beijing Shuangyi Pharmaceutical supplementary application in the review and approval recently published the current consistency evaluation of the work of the top 10 varieties, the list of zheng day day clear to declare 20 varieties, through 11, second only to the first Qilu pharmaceutical The approval of that degree amine capsule let zhengda sunny over the evaluation of the varieties to add another member images from the medicine data
At present, Zhengda Tianqing through the consistency of the evaluation of varieties are fumaric acid tinofovutwo dipolyane tablets, Entikavir dispersion tablets, metformine hydrochloride, metforminib capsules, anlithinib tablets, giferinib tablets, aureus ban tablets, acetate abitron tablets, lisavacursic tablets and so on.